Abstract:OBJECTIVE:To construct a glucosylceramide synthase (GCS)-specific small interfering RNA (siRNA) expression vector and to investigate the inhibitory effect of this siRNA on GCS expression and drug resistance in breast carcinoma cells. METHODS:Two GCS gene-specific siRNAs were designed and cloned into the expression vector pSUPER to generate the plasmids pSUPER-GCS1 and pSUPER-GCS2. Human adriamycin (ADM)-resistant breast carcinoma cells of the line MCF-7/ADR and human adriamycin-sensitive breast carcinoma cells of the line MCF-7 were cultured and transfected with pSUPER-GCS1, pSUPER-GCS2, and blank vector pSUPER as controls. The expression of GCS mRNA was assayed by RT-PCR and the expression of GCS protein was observed by flow cytometry. The 50% inhibition concentration of ADM on MCF-7/ADR cells was evaluated by MTT method. Flow cytometry was performed to determine the ratio of apoptosis. RESULTS:Double enzyme digestion analysis and DNA sequencing confirmed that pSUPER-GCS1 and pSUPER-GCS2 were successfully constructed. The GCS protein positive rate of the MCF-7/ADR cells 48 hours after transfection with pSUPER-GCS1 and pSUPER-GCS2 were 8.3% +/- 1.0% and 9.2% +/- 0.8% respectively, significantly lower than that before transfection (68.3% +/- 0.6%), with a inhibition rate of 89.4% and 88.5% respectively (both P < 0.01). Forty-eight hours after transfection with pSUPER-GCS1 and pSUPER-GCS2, the relative reversal rates of sensitivity to ADM of the MCF-7/ADR cells were 93.7% and 91.6%. Flow cytometry showed that the apoptotic rate of the MCF-7/ADR cells was 0.80 +/- 0.06 before transfection, 15.38 +/- 1.16 after transfection with pSUPER-GCS1 and 13.92 +/- 1.73 after transfection with pSUPER-GCS2 (both P < 0.05), and was 0.87 +/- 0.12 in the cells transfected with blank vector (P > 0.05). CONCLUSION:A GCS-specific small interfering RNA expression vector has been constructed successfully that suppresses the GCS expression and reverses the multidrug resistance in breast carcinoma cells by increasing the ratio of apoptosis in drug-resistant cells.

Co-Suppression Of Mdr1 (Multidrug Resistence 1) And Gcs (Glucosylceramide Synthase) Restores Sensitivity To Mutidrug Resistance Breast Cancer Cells By Rna Interference (Rnai)

Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]

Suppression of Glucosylceramide Synthase by RNA Interference Reverses Multidrug Resistance in Human Breast Cancer Cells.

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

Mdr1 (Multidrug Resistence 1) Can Regulate Gcs (Glucosylceramide Synthase) In Breast Cancer Cells

[Reversing Multidrug Resistance in Breast Cancer Cell Line MCF-7/ADR by Small Interfering RNA].

Targeting Glucosylceramide Synthase Reverses Multi-Drug Resistance in Breast Carcinoma Cells

Reversal of Multidrug Resistance of Human Breast Cancer MCF-7/ADR Cells by Small Interfering RNAs Combined with Antisense Oligodeoxyribonucleotides for Inhibition of MDR1 Gene Expression

Reversal of Multidrug Resistance in Breast Cancer MCF-7/ADR Cells by H-R3-simdr1-pamam Complexes

[Construction of Glucosylceramide Synthase-Specific Sirna Expression Vector and Its Efficiency in Reversal of Drug Resistance in Breast Carcinoma Cells].

Reversal MDR in Breast Carcinoma Cells by Transfection of Ribozyme Designed According the Secondary Structure of Mdr1 Mrna.

Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference

[Reversal of Multidrug Resistance Property of Carcinoma Cells by Down-Regulating Transcription of Mdr-1].

Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.

Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy.

Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme]

Reversal of MDR1 Gene-Dependent Multidrug Resistance Using Short Hairpin RNA Expression Vectors

Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR.

Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.

Inhibition of glucosylceramide synthase expression and reversal of multidrug resistance in human breast cancer cells by shRNA

Reversing of Multidrug Resistance Breast Cancer by Co-Delivery of P-gp Sirna and Doxorubicin Via Folic Acid-Modified Core-Shell Nanomicelles